Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs Quantumscape Corp (QS) Price & Performance

Northrop Grumman CorporationTrade
Quantumscape CorpTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs Quantumscape Corp — how do they compare? Northrop Grumman Corporation trades at $480.06 (market cap $68.83B), while Quantumscape Corp trades at $4.58 (market cap $2.82B). The key difference: Northrop Grumman Corporation is far larger — about 24.4× Quantumscape Corp's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northrop Grumman Corporation for 81 Days and Quantumscape Corp for 37 Days on average.

NOCQS
Market Cap
$68.83B$2.82B
Volume
1,081,98921,878,246
Sector
IndustrialsConsumer Cyclical
52-Week High
$768.02$18.44
52-Week Low
$473.46$4.52
Typical Hold Time
81 Days37 Days
Enterprise Value
$82.81B$2.03B
Dividend Yield
2.04%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $480.85, up 1.56% with recent earnings beats but faces technical bearish signals. The company maintains strong fundamentals with $41.95B revenue, 10.48% net margin, and attractive valuation at 15.4 P/E. Recent news highlights both contract wins and competitive losses, including Boeing's $20B Navy fighter award.

Outlook remains positive with analyst consensus at $600.62 target (25% upside) and 54% buy ratings. Key risks include defense contract volatility and competitive pressures, while strong backlog ($104.7B) and dividend growth support long-term value. The stock offers defensive exposure to elevated defense spending cycles.

Quantumscape Corp

QuantumScape (QS) trades at $4.58, up 1.33% with bearish technical signals and negative profitability metrics. The company remains pre-revenue with significant cash burn, though recent earnings beat expectations. Analyst consensus shows 72.7% hold ratings with a $10.35 price target, while insider selling and delayed commercialization timelines create headwinds.

QS faces substantial execution risk with commercialization not expected until 2029, but maintains automotive partnerships and pilot production progress. The stock trades near 52-week lows, offering potential upside to analyst targets if technology milestones are achieved, though high cash burn and competitive threats remain key concerns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOC

No sentiment data available yet.

QS
100% Buy0% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC →

About Quantumscape Corp

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.

Read more on QS →